Hanmi Science Co., Ltd. (008930.KS)
KRW 29400.0
(-2.65%)
KRW 29400.0
(-2.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 35.15 Billion | 9.45 Billion | 13.68 Billion | 13.81 Billion | 13.02 Billion | 2.7 Billion |
| Net Income | 115.12 Billion | 69.03 Billion | 42.93 Billion | 22.59 Billion | 30.74 Billion | 18.02 Billion |
| Depreciation & Amortization | 8.73 Billion | 5.47 Billion | 5.25 Billion | 6.2 Billion | 6.37 Billion | 4.6 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -25.96 Billion | -22.85 Billion | -20.24 Billion | -18.61 Billion | -10.54 Billion | -11.68 Billion |
| Other non-cash items | -62.72 Billion | -42.2 Billion | -14.25 Billion | 3.62 Billion | -13.54 Billion | -8.24 Billion |
| Investing Cash Flow | -18.67 Billion | -2.13 Billion | -2.15 Billion | -6.77 Billion | -32.45 Billion | 3.89 Billion |
| Investments in PPE | -8.76 Billion | -8.34 Billion | -2.21 Billion | -1.95 Billion | -1.96 Billion | -1.17 Billion |
| Acquisitions | -10.05 Billion | 6.38 Billion | 1.66 Million | 446.05 Thousand | 7.91 Million | 408.6 Million |
| Investment purchases | -93.38 Million | -836.29 Thousand | -1.66 Million | -4.9 Billion | -29.93 Billion | -3.16 Billion |
| Sales/Maturities of investments | 44.35 Million | 291.97 Thousand | 99.82 Million | -446.05 Thousand | -7.91 Million | 8.54 Billion |
| Other Investing Activities | 194.43 Million | -180.73 Million | -39.3 Million | 71.81 Million | -554.71 Million | -714.3 Million |
| Financing Cash Flow | -10.22 Billion | -1.07 Billion | -11.01 Billion | -9.01 Billion | 9.06 Billion | -18.19 Billion |
| Debt repayment | -12.68 Billion | -23.03 Billion | -5 Billion | -4 Billion | -40.11 Billion | -5 Billion |
| Dividends payments | -13.33 Billion | -13.19 Billion | -12.93 Billion | -12.68 Billion | -12.43 Billion | -12.19 Billion |
| Common Stock Repurchased | -7.82 Billion | -622.62 Million | -1.01 Billion | -348.33 Million | -647.28 Million | -998.14 Million |
| Common Stock Issuance | 25.36 Billion | - | -5 Billion | - | - | - |
| Other Financing Activities | -1.75 Billion | 35.77 Billion | 12.93 Billion | 8.01 Billion | 62.26 Billion | -5 Billion |
| Accounts receivables | -8.78 Billion | 2.79 Billion | -8.82 Billion | -3.56 Billion | -12.43 Billion | -4.58 Billion |
| Accounts payables | -17.71 Billion | -36.3 Billion | -19.36 Billion | -330.91 Million | -14.34 Million | -28.83 Billion |
| Inventory | 9.7 Billion | 6.23 Billion | 2.73 Billion | -8.52 Billion | 2.72 Billion | 5.54 Billion |
| Other working capital | -9.18 Billion | 4.42 Billion | 5.2 Billion | -6.19 Billion | -822.73 Million | -17.22 Billion |
| Cash at beginning of period | 21.42 Billion | 16.59 Billion | 14.84 Billion | 16.74 Billion | 26.85 Billion | 38.36 Billion |
| Cash at end of period | 27.57 Billion | 21.42 Billion | 16.59 Billion | 14.84 Billion | 16.74 Billion | 26.85 Billion |
| Capital Expenditure | -8.76 Billion | -8.34 Billion | -2.21 Billion | -1.95 Billion | -1.96 Billion | -1.17 Billion |
| Effect of forex changes on cash | -96.85 Million | -763.68 Million | 1.22 Billion | 75.05 Million | 255.57 Million | 95.6 Million |
| Net cash flow / Change in cash | 6.15 Billion | 4.82 Billion | 1.74 Billion | -1.89 Billion | -10.11 Billion | -11.5 Billion |
| Free Cash Flow | 26.38 Billion | 1.1 Billion | 11.47 Billion | 11.86 Billion | 11.05 Billion | 1.52 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 20.86 Billion | 31.73 Billion | 115.12 Billion | 34.57 Billion | 30.79 Billion | 23.03 Billion |
| Depreciation & Amortization | 2.46 Billion | 2.44 Billion | 8.73 Billion | 1.59 Billion | 2.42 Billion | 2.37 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 192.83 Million | - | - | - | - |
| Change in working capital | 2.89 Billion | -14.88 Billion | -25.96 Billion | -24.23 Billion | 5.37 Billion | -4.18 Billion |
| Other non-cash items | -498.23 Million | -7.5 Billion | -62.72 Billion | -16.91 Billion | -22.01 Billion | -7.98 Billion |
| Investing Cash Flow | -2.36 Billion | 558.22 Million | -18.67 Billion | -10.99 Billion | -3.47 Billion | -1.83 Billion |
| Investments in PPE | -2.82 Billion | -1.28 Billion | -8.76 Billion | -870.55 Million | -3.92 Billion | -1.74 Billion |
| Acquisitions | 9.66 Million | - | -10.05 Billion | -10.06 Billion | -7.08 Million | 817.85 Thousand |
| Investment purchases | -4 Billion | -4 Billion | -93.38 Million | -92.03 Million | -406.11 Thousand | -412.69 Thousand |
| Sales/Maturities of investments | 4 Billion | 6 Billion | 44.35 Million | 19.43 Million | -1.27 Million | 24.92 Million |
| Other Investing Activities | 456.71 Million | -160 Million | 194.43 Million | 15 Million | 465.6 Million | -117.29 Million |
| Financing Cash Flow | -21.54 Billion | -1.57 Billion | -10.22 Billion | 15.74 Billion | -3.72 Billion | -15.92 Billion |
| Debt repayment | -7.99 Billion | -622.85 Million | -12.68 Billion | -22.98 Billion | -2.66 Billion | -69.39 Billion |
| Dividends payments | -13.55 Billion | - | -13.33 Billion | - | - | -13.33 Billion |
| Common Stock Repurchased | - | -1.93 Billion | -7.82 Billion | -7.41 Billion | - | - |
| Common Stock Issuance | - | - | 25.36 Billion | - | - | - |
| Other Financing Activities | -10.00 | 10.00 | -1.75 Billion | 46.14 Billion | -1.05 Billion | 66.8 Billion |
| Accounts receivables | 5.9 Billion | 7.44 Billion | -8.78 Billion | -7.37 Billion | -2.92 Billion | 2.35 Billion |
| Accounts payables | 17.64 Billion | -12.88 Billion | -17.71 Billion | 25.5 Billion | 12.61 Billion | -37.44 Billion |
| Inventory | -2.9 Billion | -1.99 Billion | 9.7 Billion | -14.9 Billion | -3.46 Billion | 26.76 Billion |
| Other working capital | -107.32 Million | -7.44 Billion | -9.18 Billion | -27.45 Billion | -855.25 Million | 4.14 Billion |
| Cash at beginning of period | 26.45 Billion | 27.57 Billion | 21.42 Billion | 28.12 Billion | 18.44 Billion | 23.65 Billion |
| Cash at end of period | 28.67 Billion | 26.45 Billion | 27.57 Billion | 27.57 Billion | 28.12 Billion | 18.44 Billion |
| Capital Expenditure | -2.82 Billion | -1.28 Billion | -8.76 Billion | -870.55 Million | -3.92 Billion | -1.74 Billion |
| Effect of forex changes on cash | 407.26 Million | 430.98 Million | -96.85 Million | -323.62 Million | 289.65 Million | -685.35 Million |
| Net cash flow / Change in cash | 2.22 Billion | -1.12 Billion | 6.15 Billion | -544.94 Million | 9.67 Billion | -5.2 Billion |
| Free Cash Flow | 22.9 Billion | -1.81 Billion | 26.38 Billion | -5.84 Billion | 12.65 Billion | 11.49 Billion |
ZOREN
600703
8960
BRSF
GRAVITA
NIKL